A Vertically Integrated Platform for Programmable Terpene Synthesis
Retrosynthetic Analysis
Cyterra starts with the molecule that matters to the customer and works backward to the smartest chemo-enzymatic route. Instead of accepting the limits of plant extraction, fermentation, or classical synthesis, we identify where enzymes can create shorter, cleaner, and more selective pathways.
This allows us to turn complex terpene targets into practical development programs with clear commercial logic from day one.
Bioinformatic Fingerprinting
We map each target molecule against Cyterra’s enzyme knowledge base to identify the bioinformatic “fingerprints” most likely to unlock the desired transformation. This helps us prioritize enzyme families, active-site architectures, and substrate patterns before entering the lab.
This means less random trial-and-error and a faster path toward technically and commercially relevant hits.
Enzyme Library Screening
Cyterra screens proprietary enzyme libraries against customer-relevant terpene targets to rapidly identify first active candidates. These screening campaigns translate molecular ideas into measurable data: activity, selectivity, product identity, and early process potential.
The goal is simple: move from concept to validated product formation as quickly as possible.
Next-Generation Enzyme Engineering
Once a hit is found, Cyterra improves it using mechanism-guided, data-driven, and next-generation enzyme engineering methods. We combine structural insight, sequence intelligence, and high-throughput screening to increase selectivity, activity, stability, and process robustness.
This turns early enzyme hits into scalable catalysts designed for real industrial constraints.
Hydrophobic Formulation
Terpenes are powerful molecules, but they are also difficult to handle because they are hydrophobic, volatile, and often stressful for biological systems. Cyterra develops formulation and reaction-engineering strategies that improve substrate availability, protect the catalyst, and simplify downstream processing.
This is a critical bridge between enzyme performance in the lab and reliable production of customer samples.
Scale-Up to Gram Scale
Cyterra integrates enzyme discovery, formulation, analytics, and process development to move promising reactions toward gram-scale sample production.
This enables customers to evaluate real material for odor, performance, application behavior, and business relevance.
For investors, this creates a disciplined path from scientific discovery to commercially meaningful proof points.
FASTER
Rapid development
<6 months to gram-scale production
CUSTOMIZED
Natural Ingredients
Exclusivity by Design
INDEPENDENT
of Raw Material
No agricultural dependency
SCALABLE
Processes
Biology is not a limit
Proof studies
Every project feeds back into Cyterra’s growing platform intelligence — accelerating development, improving hit rates, and enabling faster product iteration across applications.
turnover improvement in
Ambrox study
turnover improvement in
Dihydroionone study
chiral scaffolds in
chemo-enzymatic synthesis
Our Partnership Flywheel
Every project feeds the next
01 Enzyme design
Mining and engineering
03 Analytics & Sample
Characterization and delivery
00 Target Profile
Property and manufacturing specs
05 Learning
Data Integration and refinement
02 Reaction Engineering
Hydrophobe formulation
04 Customer Feedback
Your evaluation
Built on Scientific Rigor and Industrial Experience
Cyterra combines academic excellence with industrial execution, supported by peer-reviewed research, proprietary data, and a growing patent portfolio..